Results 251 to 260 of about 74,867 (310)

Hyaluronan induces ERK activation with minimal transcriptomic changes in pancreatic α-cells. [PDF]

Biochem Biophys Rep
Sonoyama S, Mizokami A, Sano T, Jimi E, Moriyama M, Kanematsu T.   +5 more
europepmc   +1 more source

The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management. [PDF]

Front Endocrinol (Lausanne)
Deng B, Liu W, Chu Q.
europepmc   +1 more source

Machine learning-guided optimization of triple agonist peptide therapeutics for metabolic disease. [PDF]

Front Bioinform
Wong A, Guduri S, Chen T, Patel K.
europepmc   +1 more source

The Effect of GLP-1 Receptor Agonists on Epilepsy: No Appetite for Seizures. [PDF]

Epilepsy Curr
Karakis I.
europepmc   +1 more source

Liver-pancreas communication in disease and drug development. [PDF]

Acta Pharm Sin B
Jia Y, Zhu Q, Pan Q, Lu G, Xiao J.
europepmc   +1 more source

Complete Skin Remission of Lichen Planus With Tirzepatide

Australasian Journal of Dermatology, EarlyView.
Harmeet Bhullar, Emma Veysey, Tanya Bohl, Saurabh Prakash, Sarah Smithson   +4 more
wiley   +1 more source

The ESSENCE of hope: what semaglutide's Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis. [PDF]

Hepatobiliary Surg Nutr
Alamgir M, Sohal A, Kowdley KV.
europepmc   +1 more source

Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development.

J Clin Endocrinol Metab
Kontola H, Crisóstomo L, Löyttyniemi E, Koskenniemi JJ, Veijola R, Toppari J, Kero J.   +6 more
europepmc   +1 more source